Ticker > Company >

Kaya share price

Kaya Ltd.

NSE: KAYA BSE: 539276 SECTOR: Hospital & Healthcare Services  59.06 K   91   5

420.30
0 0
BSE: 01 Aug 04:01 PM

Price Summary

Today's High

₹ 424.85

Today's Low

₹ 420.2

52 Week High

₹ 569.7

52 Week Low

₹ 213.5

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

550.49 Cr.

Enterprise Value

687.93 Cr.

No. of Shares

1.31 Cr.

P/E

0

P/B

0

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  -106.61

CASH

6.63 Cr.

DEBT

144.07 Cr.

Promoter Holding

59.64 %

EPS (TTM)

₹  -20.24

Sales Growth

3.37%

ROE

0 %

ROCE

87.24%

Profit Growth

80.89 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year3.37%
3 Year15.56%
5 Year1.25%

Profit Growth

1 Year80.89%
3 Year-1.37%
5 Year4.04%

ROE%

1 Year0%
3 Year-55.94%
5 Year-41.54%

ROCE %

1 Year87.24%
3 Year-47.23%
5 Year-30.23%

Debt/Equity

-1.0317

Price to Cash Flow

37.77

Interest Cover Ratio

0.1819

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 59.64 0.00
Mar 2025 59.64 0.00
Dec 2024 59.64 0.00
Sep 2024 59.64 0.00
Jun 2024 59.79 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 15.5555355803006% for the Past 3 years.
  • The company has an efficient Cash Conversion Cycle of -334.8507 days.
  • The company has a high promoter holding of 59.64%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.97734178671028.

 Limitations

  • The company has shown a poor profit growth of -1.37300206566269% for the Past 3 years.
  • Company has a poor ROE of -55.9436666666667% over the past 3 years.
  • Company has a poor ROCE of -47.2279333333333% over the past 3 years
  • The company has a low EBITDA margin of -3.16578164601672% over the past 5 years.
  • The company has negative book value.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 53.01 52.04 52.35 58.35 54.69
Total Expenditure 133.66 39.78 46.71 57.4 48.79
Operating Profit -80.65 12.25 5.64 0.95 5.9
Other Income 1.84 10.51 0.98 1.12 4.45
Interest 6.91 7.17 7.86 7.76 7.87
Depreciation 9.05 9.1 9.39 9.7 9.45
Exceptional Items 0 0 0 0 0
Profit Before Tax -94.77 6.49 -10.63 -15.4 -6.97
Tax 0 0 0 0 0
Profit After Tax -94.77 6.49 -10.63 -15.4 -6.97
Adjusted EPS (Rs) -72.54 4.97 -8.13 -11.76 -5.32

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 117.07 140.91 178.31 210.32 217.42
Total Expenditure 99.1 126.71 204.53 291.04 191.7
Operating Profit 17.97 14.2 -26.22 -80.72 25.72
Other Income 12.51 8.91 3.86 4.61 17.81
Interest 12.37 13.72 33.3 27.37 32.41
Depreciation 32.23 34.86 29.82 35.25 37.64
Exceptional Items 0 0 0 0 0
Profit Before Tax -14.12 -25.48 -85.49 -138.72 -26.51
Tax 0 0 0 0 0
Net Profit -14.12 -25.48 -85.49 -138.72 -26.51
Adjusted EPS (Rs.) -10.81 -19.5 -65.44 -106.18 -20.24

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 13.06 13.06 13.06 13.06 13.1
Total Reserves 88.89 77.05 2.81 -129.86 -152.55
Borrowings 21.3 78.59 91.73 125.69 144.07
Other N/C liabilities 61.57 55.71 55.85 73.82 90.24
Current liabilities 92.29 98.44 139.33 138.03 141.92
Total Liabilities 277.11 322.85 302.79 220.75 236.78
Assets
Net Block 91.76 80.3 94.62 132.24 157.63
Capital WIP 0 0 0 0 0
Intangible WIP 0.89 1.13 0.81 1.2 1.31
Investments 114.44 161.11 120.98 4.05 0.76
Loans & Advances 12.34 12.29 7.88 9.36 11.91
Other N/C Assets 0.09 0 0.2 0.09 0.3
Current Assets 57.59 68.01 78.31 73.81 64.87
Total Assets 277.11 322.85 302.79 220.75 236.78
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations -14.12 -25.48 -85.49 -138.72 -26.51
Adjustment 31.96 41.43 100.9 174.97 54.97
Changes in Assets & Liabilities 0.23 18.48 31.91 3.91 -13.88
Tax Paid 0.04 0.01 -0.02 0.03 -0.01
Operating Cash Flow 18.11 34.44 47.31 40.19 14.58
Investing Cash Flow -7.07 -74.25 -1.46 -34.54 13.93
Financing Cash Flow -9.88 39.52 -31.78 -12.96 -30.43
Net Cash Flow 1.16 -0.29 14.07 -7.3 -1.93

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 59.79 59.64 59.64 59.64 59.64
anandita arjun kothari 0.04 0.04 0.04 0.04 0.04
anjali r mariwala 0.95 0.95 0.95 0.95 0.95
archana h mariwala 1.88 1.88 1.88 1.88 1.88
harsh c mariwala 3.12 3.11 3.11 3.11 3.11
harsh c mariwala with lat... - - - 10.87 10.87
harsh c mariwala with lat... - - - 10.87 10.87
harsh c mariwala with lat... - - - 10.87 10.87
harsh c mariwala with lat... - - - 10.87 10.87
late kishore v mariwala - - - 0.38 0.38
late kishore v mariwala (... - - - 0.01 0.01
late kishore v mariwala (... - - - 0.01 0.01
late kishore v mariwala (... - - - 0.01 0.01
late kishore v mariwala (... - - - 0.01 0.01
malika chirayu amin 0.14 0.14 0.14 0.14 0.14
pallavi jaikishan panchal... 0.14 0.14 0.14 0.14 0.14
paula r mariwala 0.79 0.79 0.79 0.79 0.79
rajen k mariwala 1.43 1.43 1.43 1.43 1.43
rajvi h mariwala 2.01 2.00 2.00 2.00 2.00
ravindra.k.mariwala 1.90 1.90 1.90 1.90 1.90
rishabh h mariwala 2.01 2.00 2.00 2.00 2.00
sharrp ventures capital p... 1.35 1.35 1.35 1.35 1.35
taarika rajen mariwala 0.04 0.04 0.04 0.04 0.04
harsh c mariwala with kis... 10.90 10.87 10.87 - -
harsh c mariwala with kis... 10.90 10.87 10.87 - -
harsh c mariwala with kis... 10.90 10.87 10.87 - -
harsh c mariwala with kis... 10.90 10.87 10.87 - -
kishore v mariwala 0.38 0.38 0.38 - -
kishore v mariwala (kvm a... 0.01 0.01 0.01 - -
kishore v mariwala (kvm a... 0.01 0.01 0.01 - -
kishore v mariwala (kvm t... 0.01 0.01 0.01 - -
kishore v mariwala (kvm v... 0.01 0.01 0.01 - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 40.21 40.36 40.36 40.36 40.36
llp 0.36 0.36 0.42 0.51 0.86
prashant jain - - - 1.08 1.08
shashank s khade 1.17 1.10 1.10 1.14 1.14
equity intelligence india... 1.68 1.68 1.68 1.34 -
ganesh srinivasan 3.05 3.04 3.04 3.04 -
eq india fund 1.26 1.26 1.26 - -
tikri management private ... - 1.03 1.03 - -
jainam broking limited 1.02 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2025
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit ACUITE
Credit SMERA
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY23
Concall Q4FY20
Concall Q3FY21
Concall Q2FY21
Concall Q1FY21
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY24
Presentation Q4FY22
Presentation Q4FY21
Presentation Q3FY22
Presentation Q3FY21
Presentation Q2FY24
Presentation Q2FY21
Presentation Q1FY23
Presentation Q1FY22
Presentation Q1FY21

Company News

Kaya informs about analyst meet 30 Jul, 11:51 AM Kaya informs about outcome of postal ballot 12 Jun, 3:33 PM Kaya informs about press release 30 May, 12:53 PM Kaya - Quaterly Results 28 May, 10:29 PM Kaya - Quaterly Results 28 May, 10:29 PM Kaya informs about newspaper advertisement 13 May, 12:36 PM Kaya informs about integrated filing 29 Jan, 3:34 PM Kaya - Quaterly Results 28 Jan, 5:00 PM Kaya - Quaterly Results 28 Jan, 5:00 PM Kaya - Quaterly Results 28 Jan, 5:00 PM Kaya informs about conference call 20 Jan, 12:13 PM Kaya informs about board meeting 17 Jan, 9:40 AM Kaya informs about compliances-certificate 13 Jan, 2:51 PM Kaya - Quaterly Results 28 Oct, 3:42 PM Kaya - Quaterly Results 28 Oct, 3:42 PM Kaya informs about board meeting 16 Oct, 1:08 PM Kaya informs about allotment of equity shares under ESOP 19 Sep, 5:29 PM Kaya - Quaterly Results 6 Aug, 4:11 PM Kaya - Quaterly Results 6 Aug, 4:11 PM Kaya - Quaterly Results 6 Aug, 4:11 PM Kaya informs about press release 16 Jul, 2:37 PM Kaya’s arm sells entire shareholding in Kaya Middle East FZE 11 Jun, 11:41 AM Kaya informs about corrigendum to audited financial results 28 May, 9:48 AM Kaya - Quaterly Results 27 May, 4:46 PM Kaya - Quaterly Results 27 May, 4:46 PM Kaya - Quaterly Results 27 May, 4:46 PM Kaya informs about board meeting 18 May, 2:20 PM Kaya - Quaterly Results 30 Jan, 4:06 PM Kaya - Quaterly Results 30 Jan, 4:06 PM Kaya - Quaterly Results 30 Jan, 4:06 PM Kaya informs about press release 27 Dec, 1:08 PM Kaya informs about outcome of board meeting 21 Dec, 4:46 PM Kaya’s arm sells entire stake in MMC, MMCSC 15 Nov, 9:47 AM Kaya informs about disclosure 3 Nov, 9:57 AM Kaya - Quaterly Results 31 Oct, 4:13 PM Kaya - Quaterly Results 31 Oct, 4:13 PM Kaya - Quaterly Results 31 Oct, 4:13 PM Kaya informs about board meeting 20 Oct, 5:02 PM Kaya’s arm acquires 100% stake in SAMIC 29 Sep, 9:38 AM Kaya informs about disclosure 12 Sep, 5:13 PM Kaya - Quaterly Results 27 Jul, 4:14 PM Kaya - Quaterly Results 27 Jul, 4:14 PM Kaya - Quaterly Results 27 Jul, 4:14 PM Kaya informs about analyst meet 21 Jul, 5:10 PM Kaya informs about notice of postal ballot 18 Jul, 5:18 PM Kaya’s arm acquires 99% stake in Kaya Skin Care clinic LLC 12 Jul, 9:58 AM Kaya’s arm acquires 100% stake in Kaya Beauty Clinic LLC 31 May, 5:40 PM Kaya - Quaterly Results 24 May, 6:50 PM Kaya - Quaterly Results 24 May, 6:50 PM Kaya’s arm acquires entire stake in Kaya Beauty Clinic 14 Mar, 9:20 AM

Kaya Stock Price Analysis and Quick Research Report. Is Kaya an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Kaya and its performance over the period of time. Kaya stock price today is Rs 420.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Kaya cash from the operating activity was Rs 14.5759 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Kaya has a Debt to Equity ratio of -1.0317 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Kaya , the EPS growth was 80.9374 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Kaya has OPM of 11.8311310210971 % which is a bad sign for profitability.
     
  • ROE: Kaya have a poor ROE of 0 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Kaya is Rs 420. One can use valuation calculators of ticker to know if Kaya share price is undervalued or overvalued.
Last Updated on:
Brief about Kaya
X